Moxifloxacin

Also known as: Avelox, Vigamox, Bay 12-8039, Moxeza, Avalox, Avdox, CS-83, MFCD04117996, 1-cyclopropyl-6-fluoro-8-methoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid, 1-cyclopropyl-6-fluoro-8-methoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid, (4aS-cis)-1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-3-quinolinecarboxylic acid, 3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-

Moxifloxacin (CAS 151096-09-2) is a compound in the Organic Compounds category listed in the Jingsj chemical database. It has the molecular formula C21H24FN3O4 and a molecular weight of 401.43 g/mol. Key properties include a melting point of 193-195 °C(lit.), a boiling point of 636.4±55.0 °C at 760 mmHg, a density of 1.4±0.1 g/cm3 and a flash point of 338.7±31.5 °C. No supplier offers are currently listed; request a quote. Record last updated Aug 21, 2026.

CAS No.: 151096-09-2
Jingsj CID: J-44394-7
Molecular Formula: C₂₁H₂₄FN₃O₄
Molecular Weight: 401.43 g/mol
Category: Organic Compounds
Last updated: 8/21/2026

Request MSDS / TDS

No offers for this compound yet.

Request a quote

Physicochemical Properties

Melting Point	193-195 °C(lit.)
Boiling Point	636.4±55.0 °C at 760 mmHg
Density	1.4±0.1 g/cm3
Flash Point	338.7±31.5 °C
PSA	83.80000
LogP	1.60
Vapor Pressure	0.0±2.0 mmHg at 25°C
Refractive Index	1.633

Activity & Biological Data

Additional Information	[1]. Balfour, J.A. and H.M. Lamb, Moxifloxacin: a review of its clinical potential in the management of community-acquired respiratory tract infections. Drugs, 2000. 59(1): p. 115-39. [2]. Culley, C.M., et al., Moxifloxacin: clinical efficacy and safety. Am J Health Syst Pharm, 2001. 58(5): p. 379-88. [3]. Ioannidis, O., et al., Effect of moxifloxacin on the survival, lipid peroxidation and inflammation of immunosuppressed rats with soft tissue infection from Stenotrophomonas maltophilia. Microbiol Immunol, 2013.

Additional Information

[1]. Balfour, J.A. and H.M. Lamb, Moxifloxacin: a review of its clinical potential in the management of community-acquired respiratory tract infections. Drugs, 2000. 59(1): p. 115-39. [2]. Culley, C.M., et al., Moxifloxacin: clinical efficacy and safety. Am J Health Syst Pharm, 2001. 58(5): p. 379-88. [3]. Ioannidis, O., et al., Effect of moxifloxacin on the survival, lipid peroxidation and inflammation of immunosuppressed rats with soft tissue infection from Stenotrophomonas maltophilia. Microbiol Immunol, 2013.

Customs & Trade Information

HS Code	29329970

Frequently Asked Questions

What is the CAS number of Moxifloxacin?

The CAS number of Moxifloxacin is 151096-09-2.

What are the molecular formula and molecular weight of Moxifloxacin?

Moxifloxacin has molecular formula C21H24FN3O4 and molecular weight 401.43 g/mol.

What are the upstream and downstream products of Moxifloxacin?

For Moxifloxacin, Upstream Products: 1-Cyclopropyl-6,7-difluoro-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid, (S,S)-2,8-Diazabicyclo[4.3.0]nonane, Moxifloxacin hydrochloride; Downstream Products: Moxifloxacin hydrochloride.

Data compiled from public chemical databases such as PubChem and supplier catalogs; supplier offers are provided by suppliers.

Last updated: 8/21/2026

How to cite: Jingsj. "Moxifloxacin (CAS 151096-09-2)". Jingsj Chemical Database. https://www.jingsj.com/compound/J-44394-7 (accessed 2026-11-09).

Data for reference only; verify product details with suppliers before purchase.